MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/60/0.1/20.12.24 Stock

Warrant

DE000MB3F1X9

Market Closed - Börse Stuttgart 02:28:03 2024-07-05 pm EDT
1.75 EUR +1.16% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/60/0.1/20.12.24
Current month-8.38%
1 month-15.87%
Date Price Change
24-07-05 1.75 +1.16%
24-07-04 1.73 +1.17%
24-07-03 1.71 -2.84%
24-07-02 1.76 -3.30%
24-07-01 1.82 -4.71%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 02:28 pm EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN MB3F1X
ISINDE000MB3F1X9
Date issued 2023-02-08
Strike 60 $
Maturity 2024-12-20 (168 Days)
Parity 10 : 1
Emission price 1.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.1
Lowest since issue 0.57
Spread 0.02
Spread %1.12%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
154.4 USD
Average target price
174.6 USD
Spread / Average Target
+13.10%
Consensus